Gadobenate dimeglumine (BOPTA) enhanced MR imaging: Patterns of enhancement in normal liver and cirrhosis
暂无分享,去创建一个
R. Manfredi | A. Cotroneo | A. Spinazzi | P. Marano | R. Baron | G. Pirovano | G. Maresca | A. De Franco | A. D. de Gaetano | R. Manfredi | Giampaolo Pirovano
[1] A. Spinazzi,et al. Interim results of phase II clinical testing of gadobenate dimeglumine. , 1994, Investigative radiology.
[2] G. Vittadini,et al. Preclinical profile of Gd-BOPTA. A liver-specific MRI contrast agent. , 1990, Investigative radiology.
[3] R. Bryan,et al. MR imaging of susceptibility-induced magnetic field inhomogeneities. , 1988, Radiology.
[4] R. Passariello,et al. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver. , 1990, Radiology.
[5] C. de Haën,et al. Soluble‐type hepatobiliary contrast agents for MR imaging , 1993, Journal of magnetic resonance imaging : JMRI.
[6] G. Dodd,et al. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique. , 1992, AJR. American journal of roentgenology.
[7] O. Matsui,et al. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. , 1992, Radiology.
[8] G. Morana,et al. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application. , 1996, Radiology.
[9] E M Haacke,et al. Reduction of T2* dephasing in gradient field-echo imaging. , 1989, Radiology.
[10] K. Ohtomo,et al. Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. , 1993, Radiology.
[11] F. Cavagna,et al. Evaluation of the hepatocyte‐specific contrast agent gadobenate dimeglumine for MR imaging of acute hepatitis in a rat model , 1997, Journal of magnetic resonance imaging : JMRI.
[12] T. Murakami,et al. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP). , 1996, Radiology.
[13] C. McMahon,et al. Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers. , 1992, AJR. American journal of roentgenology.
[14] M. Bernardino,et al. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging. , 1993, Radiology.
[15] O. Matsui,et al. Delayed enhancement of fibrotic areas in hepatic masses: CT-pathologic correlation. , 1992, Journal of computer assisted tomography.
[16] G. Dodd,et al. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. , 1994, Radiology.
[17] H. Popper. Pathologic aspects of cirrhosis. A review. , 1977, The American journal of pathology.